Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings

European Radiology

Volumn 21, Issue 8, 2011, Pages 1699-1708

  Chikui, Toru ^a   Kawano, Shintaro ^a   Kawazu, Toshiyuki ^a   Hatakenaka, Masamitsu ^b,c   Koga, Syouzou ^c   Ohga, Masahiro ^c   Matsuo, Yoshio ^b   Sunami, Syunya ^b   Sugiura, Tsuyoshi ^c   Shioyama, Yoshiyuki ^b   Obara, Makoto ^d   Yoshiura, Kazunori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

Contrast media; Magnetic resonance imaging; Oral cancer; Pharmacokinetics; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; TS 1; UFT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DRUG ELIMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUTH CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RADIOTHERAPY DOSAGE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 80052679676     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2102-x     Document Type: Article

References (37)

1. Adelstein DJ, Kalish LA, Adams GL, Wagner H Jr, Oken MM, Remick SC, Mansour EG, Haselow RE (1993) Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol 11:2136-2142. (Pubitemid 23332249)
2. Dragovic J, Doyle TJ, Tilchen EJ, Nichols RD, Benninger MS, Carlson ER, Boyd SB, Jacobsen GR (1995) Accelerated fractionation radiotherapy and concomitant chemotherapy in patients with stage IV inoperable head and neck cancer. Cancer 176:1655-1661.
3. BenassoM, Corvò R, Numico G, CavallariM, Blengio F, Sanguineti G, Rosso M, Merlano M (1995) Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study. Anticancer Res 15:2651-2654. (Pubitemid 26095076)
4. Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, Salama J, Vokes EE (2010) Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 120:93-99.
5. Yamamoto T, Oku N, Tatemoto Y, Ueta E, Kamatani T, Sasabe E, Osaki T (2006) Concomitant chemo-radio-immunotherapy has a lethal therapeutic effect on tongue carcinomas independent of the clinical stage and histological characteristics of the tumor. Oral Oncol 42:873-879. (Pubitemid 44428219)
6. Denys D, Kumar P, Wong FS, Newman LA, Robbins KT (1997) The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma. Am J Surg 174:561-564. (Pubitemid 27486027)
7. Jaulerry C, Dubray B, Brunin F, Rodriguez J, Point D, Blaszka B, Asselain B, MosseriV, Brugere J, Cosset JM (1995) Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 33:271-279.
8. Mäntylä M, Kortekangas AE, Valavaara RA, Nordman EM (1979) Tumour regression during radiation treatment as a guide to prognosis. Br J Radiol 52:972-977. (Pubitemid 10171247)
9. Geets X, Tomsej M, Lee JA, Duprez T, Coche E, Cosnard G, Lonneux M, Grégoire V (2007) Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85:105-115. (Pubitemid 47570061)
10. Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, Jacobs F, Grégoire V, Lonneux M, Vakaet L, Vanderstraeten B, Bauters W, Bonte K, Thierens H, De Neve W (2007) Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68:126-135. (Pubitemid 46589860)
11. Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Ohnishi K, Sunami S, Kamitani T, Setoguchi T, Yoshiura T, Nakashima T, Nishikawa K, Honda H (2010) Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.05.051.
12. King AD, Mo FK, Yu KH, Yeung DK, Zhou H, Bhatia KS, Tse GM, Vlantis AC, Wong JK, Ahuja AT (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213-2220.
13. Vandecaveye V, Dirix P, De Keyzer F, de Beeck KO, Vander Poorten V, Roebben I, Nuyts S, Hermans R (2010) Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 20:1703-1714.
14. Kato H, Kanematsu M, Tanaka O, Mizuta K, Aoki M, Shibata T, Yamashita T, Hirose Y, Hoshi H (2009) Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 19:986-994.
15. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:621-628.
16. Buckley DL, Kerslake RW, Blackband SJ, Horsman A (1994) Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. Magn Reson Med 32:646-651. (Pubitemid 24338213)
17. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. JMagn Reson Imaging 10:223-232. (Pubitemid 29463104)
18. Roberts TP (1997) Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 7:82-90. (Pubitemid 28365642)
19. Landis CS, Li X, Telang FW, Molina PE, Palyka I, Vetek G, Springer CS Jr (1999) Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn Reson Med 42:467-478. (Pubitemid 29416208)
20. Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A, Poptani H (2010) Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 31:262-268.
21. Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL (2007) Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 189:849.
22. Padhani AR, Hayes C, Assersohn L, Powles T, Makris A, Suckling J, Leach MO, Husband JE (2006) Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 239:361-374.
23. Mussurakis S, Buckley DL, Bowsley SJ, Carleton PJ, Fox JN, Turnbull LW, Horsman A (1995) Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Invest Radiol 30:650-662.
24. Yamashita Y, Baba T, Baba Y, Nishimura R, Ikeda S, Takahashi M, Ohtake H, Okamura H (2000) Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 216:803-809. (Pubitemid 30660858)
25. George ML, Dzik-Jurasz AS, Padhani AR, Brown G, Tait DM, Eccles SA, Swift RI (2001) Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 88:1628-1636. (Pubitemid 33124241)
26. Juan CJ, Chen CY, Jen YM, Liu HS, Liu YJ, Hsueh CJ, Wang CY, Chou YC, Chai YT, Huang GS, Chung HW (2009) Perfusion characteristics of late radiation injury of parotid glands: quantitative evaluation with dynamic contrast-enhanced MRI. Eur Radiol 19:94-102.
27. Oberholzer K, Pohlmann A, Schreiber W, Mildenberger P, Kunz P, Schmidberger H, Junginger T, Düber C (2008) Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 27:1296-1301. (Pubitemid 351770680)
28. Roberts C, Parker GJ, Rose CJ, Watson Y, O'Connor JP, Stivaros SM, Jackson A, Rushton VE (2008) Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling-initial experience. Radiology 246:845-853.
29. Van Cann EM, Rijpkema M, Heerschap A, van der Bilt A, Koole R, Stoelinga PJ (2008) Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma. Oral Oncol 44:1147-1154.
30. Shimosato Y, Oboshi S, Baba K (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinoma. Jpn J Clin Oncol 1:19-35.
31. Kitagawa Y, Sadato N, Azuma H, Ogasawara T, Yoshida M, Ishii Y, Yonekura Y (1999) FDG PET to evaluate combined intraarterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 40:1132-1137. (Pubitemid 29315503)
32. Müller-Schimpfle M, Rieber A, Kurz S, Stern W, Claussen CD (1995) Dynamic 3D MR mammography using a rapid gradientecho sequence. Rofo 162:13-19.
33. Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A (2001) Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 14:457-463. (Pubitemid 32906564)
34. Tohnai I, Hayashi Y, Yambe M, Mitsudo K, Mizutani H, Ueda M (1995) The clinical and histopathological effects of combined chemotherapy using cisplatin and peplomycin to treat cancer of the tongue. Nagoya J Med Sci 58:171-177.
35. Abbas B, Hume SP, McCullough JS, Wilson DJ, Stewart PC, Carr KE (1990) Early morphological changes in blood capillaries of mouse duodenal villi induced by X-irradiation. J Submicrosc Cytol Pathol 4:609-614. (Pubitemid 20349999)
36. Jonsson K, Libshitz HI, Osborne BM (1978) Lymphangiographic changes after radiation therapy. AJR Am J Roentgenol 131:803- 806. (Pubitemid 9011704)
37. Abbas B, Boyle FC, Wilson DJ, Nelson AC, Carr KE (1990) Radiation induced changes in the blood capillaries of rat duodenal villi: a corrosion cast, light and transmission electron microscopical study. J Submicrosc Cytol Pathol 22:63-70. (Pubitemid 20110950)